Ki Dam Kim

Ki Dam Kim

Auto-generated profile, based on publicly available information

Ki Dam Kim


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 February 2026 in Nutrients
Verified
Journal Article
Open access
PDF file
MCMoon Kyun Cho
Moon Kyun Cho
YLYeji Lee
Yeji Lee
KKKi Dam Kim
Ki Dam Kim
MCMin Hyuk Choi
Min Hyuk Choi
SLSang-Han Lee
Sang-Han Lee
Yoon-Jin LeeYoon-Jin Lee
Yoon-Jin Lee
Background/Objectives: Although curcumin (CUR) and resveratrol (RSV) are natural polyphenolic compounds with reported anticancer and anti-inflammatory properties, their combined anticancer effects in melanoma cells remain incompletely characterized. This study aimed to evaluate the anticancer efficacy of CUR and RSV, individually, and in combination, in melanoma cells compared to normal melanocytes. Methods: Cell viability and intracellular ATP levels were quantified, and dose–response analyses performed. Cellular morphology and nuclear alterations were examined by phase-contrast microscopy and DAPI staining. Cell cycle distribution and apoptosis were analyzed by Muse™ Cell Analyzer with dedicated assay kits. Survival- and death-related signaling proteins were evaluated by Western blotting. Results: Combined treatment with CUR (60 μM) and RSV (40 μM) for 48 h synergistically reduced melanoma cell viability and markedly depleted intracellular ATP levels, while exerting minimal cytotoxic effects on normal melanocytes. CUR/RSV co-treatment induced pronounced morphological and nuclear alterations, significantly increased apoptotic cell populations, and modulated key signaling pathways regulating cell survival and programmed cell death in melanoma cells. Conclusions: These findings demonstrate that combined CUR and RSV treatment exerts enhanced, melanoma-selective anticancer activity while sparing normal melanocytes. The results provide a strong experimental rationale for further in vivo validation of CUR/RSV-based combination strategies as a potential therapeutic approach for melanoma.

Verified
Journal Article
Open access
PDF file
YLYeji Lee
Yeji Lee
SLSang-Han Lee
Sang-Han Lee
DCDongsic Choi
Dongsic Choi
HNHae-Seon Nam
Hae-Seon Nam
KKKi Dam Kim
Ki Dam Kim
Yoon-Jin LeeYoon-Jin Lee
Yoon-Jin Lee
Malignant melanoma exhibits high metastatic potential and resistance to chemotherapy, highlighting the need for novel therapeutic strategies. Resveratrol, a natural polyphenol, exerts anticancer effects by modulating cellular metabolism and apoptosis. In this study, we investigated its effects on hexokinase II (HK II) and pyruvate kinase M2 (PKM2) in G361 and SK-MEL-24 melanoma cells. Resveratrol reduced HK II and PKM2 expression and enzymatic activity, resulting in decreased ATP production and inhibition of glycolysis-dependent energy metabolism. Apoptosis was induced, as indicated by increased cleaved caspase-3, elevated Bax/Bcl-2 ratio, and enhanced caspase-3/7 activity. Necroptosis was also activated, evidenced by increased phosphorylation of RIP and MLKL. Cell cycle analysis revealed G0/G1 phase arrest, and Annexin V staining confirmed apoptosis. These effects were stronger in G361 cells than in SK-MEL-24 cells, suggesting that HK II- and PKM2-dependent metabolic traits influence resveratrol sensitivity. In summary, resveratrol activates both apoptotic and necroptotic cell-death pathways by inhibiting HK II and PKM2, highlighting its potential as a metabolism-targeted therapeutic agent for malignant melanoma.

1 January 2024 in Annals of Dermatology
Verified
Journal Article
Open access
PDF file
Yoon-Jin LeeYoon-Jin Lee
Yoon-Jin Lee
KKKi Dam Kim
Ki Dam Kim
SPSukh Que Park
Sukh Que Park
DKDong Sung Kim
Dong Sung Kim
YCYu Sung Choi
Yu Sung Choi
MCMoon Kyun Cho
Moon Kyun Cho
Lee YJ, et al. Ann Dermatol. 2024 Jun;36:e48. https://doi.org/10.5021/ad.24.008

29 September 2025 in Biomedicines
Verified
Journal Article
Open access
PDF file
Yoon-Jin LeeYoon-Jin Lee
Yoon-Jin Lee
KKKi Dam Kim
Ki Dam Kim
MCMin Hyuk Choi
Min Hyuk Choi
SPSukh Que Park
Sukh Que Park
YCYu Sung Choi
Yu Sung Choi
MCMoon Kyun Cho
Moon Kyun Cho
Objectives: Caffeic acid (CA), a naturally occurring phenolic compound exhibiting antioxidant and anti-inflammatory effects, has demonstrated anticancer activity against several tumor types. Nevertheless, its involvement in melanoma and its effects on the GSK3β signaling pathway have not been fully elucidated. This study aimed to assess the expression of p-GSK3β in melanoma tissues and to evaluate the anti-melanoma efficacy of CA. Methods: Western blot analysis was performed to determine the expression levels of p-GSK3β in melanoma and normal skin samples. G361 melanoma cells were exposed to CA, after which cell viability, apoptotic induction, cell cycle distribution, and related signaling molecules were examined. Results: Significantly increased p-GSK3β levels were identified in melanoma tissues. CA exposure decreased cell viability, triggered apoptosis, and elevated p-GSK3β levels in G361 melanoma cells. Moreover, CA induced the upregulation of p53 and p21 while concomitantly downregulating cyclin D1 and Bcl-2. Conclusions: These results suggest that CA inhibits melanoma cell growth through activation of a pathway involving the tumor suppressor p53, rather than through modulation of GSK3β signaling.

1 January 2023 in Annals of Dermatology
Verified
Journal Article
Open access
PDF file
Yoon-Jin LeeYoon-Jin Lee
Yoon-Jin Lee
YCYu Sung Choi
Yu Sung Choi
SKSooyoung Kim
Sooyoung Kim
JHJae Young Heo
Jae Young Heo
DKDong Sung Kim
Dong Sung Kim
MCMoon Kyun Cho
Moon Kyun Cho
Lee YJ, et al. Ann Dermatol. 2023 Dec;35(6):439-450. https://doi.org/10.5021/ad.23.023

7 April 2026 in Life
Verified
Journal Article
Open access
PDF file
MCMoon Kyun Cho
Moon Kyun Cho
YLYeji Lee
Yeji Lee
KKKi Dam Kim
Ki Dam Kim
MCMin Hyuk Choi
Min Hyuk Choi
SPSukh Que Park
Sukh Que Park
Yoon-Jin LeeYoon-Jin Lee
Yoon-Jin Lee
Bioactive polyphenols are increasingly recognized as modulators of multiple biological processes relevant to human health and disease. Among these compounds, genistein, a soy-derived isoflavone, and butein, a naturally occurring chalcone, have been investigated for their anticancer, anti-inflammatory, and metabolic regulatory activities, primarily in in vitro and preclinical experimental models. Despite their distinct chemical structures, available evidence indicates that genistein and butein can influence key molecular pathways involved in cell survival, energy metabolism, and programmed cell death. Experimental studies have shown that these compounds may modulate PI3K/Akt and MAPK/ERK signaling, alter glycolytic and mitochondrial metabolism, and induce apoptotic responses through caspase activation and poly(ADP-ribose) polymerase cleavage. This review provides a comprehensive overview of the chemical characteristics, bioavailability, and proposed molecular mechanisms of action of genistein and butein, with a particular focus on their potentially convergent roles in metabolic reprogramming and apoptotic signaling networks. In addition, we discuss the conceptual basis for combination approaches involving these compounds, emphasizing systems-level pathway modulation rather than definitive pharmacological synergy. Importantly, many of the reported biological effects have been observed under experimental conditions using concentrations that may exceed physiologically achievable concentrations, thereby limiting direct extrapolation to clinical settings. Furthermore, the current evidence base is constrained by limited in vivo validation and a lack of robust clinical data, particularly for butein. Future studies are required to better define pharmacokinetic properties, physiological relevance, and context-dependent biological effects, thereby providing a more rigorous framework for future evaluation of the translational potential of genistein and butein.